Skip to main content

Table 1 Clinical characteristics of a cohort of 33 brain specimens from people with HIV

From: Transcriptomic analysis of brain tissues identifies a role for CCAAT enhancer binding protein β in HIV-associated neurocognitive disorder

  Cognitive normal (n = 10) Asymptomatic neurocognitive impairment (n = 10) Minor neurocognitive dysfunction (n = 10) HIV-associated dementia (n = 3)
Age 41.7 ± 8.1 41.7 ± 10.8 43.1 ± 6.7 40.7 ± 2.1
Sex (fm:m) 0:10 1:09 1:09 1:02
Postmortem interval 33.3 ± 67.5 21.4 ± 28.4 15.5 ± 14.4 9.3 ± 3.01
Education 13.0 ± 2.3 12.22 ± 3.4 12.0 ± 3.46 16.0 ± 3.5
CD4 151.6 ± 151.2 68.7 ± 73.9 35.3 ± 55.4 98.0 ± 155.1
VL (log) 3.3 ± 1.6 3.9 ± 1.3 5.0 ± 0.8 4.4 ± 2.4
Duration on ART (months) 53.3 ± 28.2 56.3 ± 86.5 35.7 ± 19.6 16.0 ± 0.0